Cantitate/Preț
Produs
Total produse
Vezi coșul
Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside de Shafiqur Rahman

Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside: Progress in Molecular Biology and Translational Science, cartea 167

Editat de Shafiqur Rahman
en Limba Engleză Hardback – 5 oct 2019
Progress in Molecular Biology and Translational Science, Volume 167, provides the most topical, informative and exciting monographs available on a wide variety of research topics related to Models and Biological Targets in Drug Discovery for Attention Deficit Hyperactivity Disorder, Novel Targets for Parkinson-Depression Co-morbidity. Utility of Cannabidiol (CBD) in Neuropsychiatric Disorders: A Short Review of the Recent Pre-clinical and Clinical Findings, The Many Sides of Microglia in Alcohol Use Disorders, Stress, Anxiety, Molecular Targets and More, Calcineurin Signaling in Psychiatric Disorders, Emerging Evidence for the Role of Pituitary Adenylate Cyclase- Activating Peptide (PACAP) in Neuropsychiatric Disorders, and more.


  • Includes comprehensive coverage of molecular biology
  • Presents ample use of tables, diagrams, schemata and color figures to enhance the reader's ability to rapidly grasp the information provided
  • Contains contributions from renowned experts in the field
Citește tot Restrânge

Din seria Progress in Molecular Biology and Translational Science

Preț: 77985 lei

Preț vechi: 101970 lei
-24% Nou

Puncte Express: 1170
Preț estimativ în valută:
14923€ • 15620$ • 12420£

Carte tipărită la comandă

Livrare economică 24 martie-07 aprilie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780128188552
ISBN-10: 0128188553
Pagini: 266
Dimensiuni: 152 x 229 mm
Greutate: 0.53 kg
Editura: ELSEVIER SCIENCE
Seria Progress in Molecular Biology and Translational Science

Public țintă

Each volume of Progress in Molecular Biology and Translational Science will be useful for scientists working actively in a field, including those at levels ranging from graduate student to senior investigator. Volumes also are appropriate for new investigators to a field who wish to familiarize themselves with the latest work.

Cuprins

1. Novel targets for parkinsonism-depression comorbidity
Yousef Tizabi, Bruk Getachew, Antonei B. Csoka, Kebreten F. Manaye and Robert L. Copeland
2. Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings
Sonja Elsaid, Stefan Kloiber and Bernard Le Foll
3. Stress, psychiatric disorders, molecular targets, and more
Fatin Atrooz, Hesong Liu and Samina Salim
4. Calpain in the cleavage of alpha-synuclein and the pathogenesis of Parkinson's disease
Ramsha Shams, Naren L. Banik and Azizul Haque
5. Calcineurin signaling as a target for the treatment of alcohol abuse and neuroinflammatory disorders
Patrick J. Ronan, Sarah A. Flynn and Thomas P. Beresford
6. Emerging evidence for the role of pituitary adenylate cyclase-activating peptide in neuropsychiatric disorders
Kabirullah Lutfy and Shankar Gollapudi
7. Glial mechanisms underlying major depressive disorder: Potential therapeutic opportunities
Shafiqur Rahman and Sami Alzarea
8. Its complicated: The relationship between alcohol and microglia in the search for novel pharmacotherapeutic targets for alcohol use disorders
Jennifer K. Melbourne, K. Ryan Thompson, Hui Peng and Kimberly Nixon
9. Microglia as possible therapeutic targets for autism spectrum disorders
Megumi Andoh, Yuji Ikegaya and Ryuta Koyama